Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market Trends

Statistics for the 2023 & 2024 Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics market trends, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Industry

This section covers the major market trends shaping the APAC Pancreatic Cancer Therapeutics & Diagnostics Market according to our research experts:

Radiotherapy is Expected to register a High CAGR

Radiation therapy is a cancer treatment that uses high-energy radiation, in the form of waves, such as x-rays, or particles, such as protons, to kill cancer cells or prevent them from growing and dividing. Radiation therapy can prevent pancreatic tumors from growing and sometimes shrinks them. Since radiation therapy is directed to a specific (focused) area, it is considered a local treatment.

The demand for radiation therapy in Asia-pacific is also expected to increase as stated by the 2018 report by Noorazrul Yahya et al., published in the Asia-pacific Journal of Clinical Oncology. According to the estimates of the report, the number of radiotherapy fractions needed in 2025 and 2035 is expected to increase to 11.1 million and 14.1 million, respectively, compared to 7.6 million in 2015 in Southeast Asia.

As the demand for increases, it is expected that its application in pancreatic cancer will also increase. This is expected to help the market growth in the region.

Graph

Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)